Taiwan Penalizes Deutsche Bank, 3 Others for Currency Trades

InvestorPlace

7 Growth Stocks That Won’t Be Stopped in 2021

Investors typically love growth stocks with exciting stories. That’s because they promise powerful upside potentials and can increase revenue and earnings faster than their peers. So, the prospect of investing in these kinds of picks should appeal to many investors. However, above-market growth potential also suggests higher-than-average risk. In fact, recent research by scholars at the University of Akron highlighted,“Growth stocks are expected to be currently trading at prices higher than their intrinsic value because of the growth potential.” Similarly, researchers at Rowan University note that “growth stocks have a greater sensitivity to most major stock market declines.” In other words, there’s little safety margin for investors if a business fails to grow as quickly as expected. Growth stocks are priced for perfect execution, without much room for error. A stock can easily plummet if the company fails to meet expectations.InvestorPlace – Stock Market News, Stock Advice & Trading Tips But broader markets and growth names have shown significant momentum in the past year. As a result, market participants find it challenging to balance the predictability of future returns and the high valuation levels we’re currently seeing. Therefore, it’s crucial to find the right picks to maximize your odds of success in the long-run. Some may carry less risk than others, based on their competitive advantages, market positioning or size. 8 Biometric Stocks to Consider as We Eye a Return to Normal With that in mind, the following stocks carry a certain business momentum and long-term potential into 2021: Blackrock Future Innovators ETF (NYSEARCA:BFTR) Cloudera (NYSE:CLDR) Crowdstrike (NASDAQ:CRWD) Direxion Work From Home ETF (NYSEARCA:WFH) iShares Expanded Tech-Software Sector ETF (BATS:IGV) Ørsted (OTCMKTS:DNNGY) Upwork (NASDAQ:UPWK) Growth Stocks to Buy: BlackRock Future Innovators ETF (BFTR) Source: Shutterstock 52-Week Range: $35.22 — $53.67Expense Ratio: 0.8%, or $80 on a $10,000 investment First on my list of growth stocks is actually an exchange-traded fund (ETF), the Blackrock Future Innovators ETF. This fund seeks long-term capital appreciation by holding innovative companies. Its focus is small-cap and mid-cap businesses. As an actively managed fund, its managers also target industries they believe could impact the future of the global economy. BFTR stock — which has 62 holdings — tracks the Russell 2500 Growth Index. As a new fund, it started trading in late September and currently has about $11.3 million under management. The Information Technology and Health Care sectors have the highest weighting in the ETF, each with a little over 30%. They’re followed by Consumer Discretionary stocks at 16.51%, Industrials at 10.74% and Consumer Staples at 5.4%. The fund’s holdings include companies like law enforcement technology solutions provider Axon (NASDAQ:AXON), the online car-buying platform Vroom (NASDAQ:VRM) and the patient-intake software solutions provider Phreesia (NYSE:PHR). BFTR returned close to 40% in the last three months. In other words, $1,000 invested in the fund before that period would now be worth around $1,400. So far this year, the ETF has returned about 14% year-to-date (YTD). As the busy earnings season marches on, investors should be ready for increased volatility. While the fund’s investment proposition is solid, this ETF could also come under pressure in the short-run. Any decline of 5% to 7% from the current levels would improve the margins of safety for long-term investors. Cloudera (CLDR) Source: Shutterstock 52-Week Range: $4.76 — $16.19 Cloudera provides enterprise software for cloud platforms that can be used for data management and analytics. Back in early December, the company released its third-quarter results. Revenue was $217.9 million, representing an increase of 10%. Non-GAAP net income came at…